Ureas and their use in the treatment of heart failure
US8110595B2 · kind B2 · utility
32Cited by
36References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2005 |
| Grant date | Feb 7, 2012 |
| Priority date | — |
| Expiry date | Sep 15, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.